PressRoom

On going Projects table
Subjects Yungjin Pharm.¡¯s asthma/COPD medication selected as ¡°Ministry of Knowledge Economy, futurity industry leading technology hit 3137
Write Marketing Date 2012-01-18

2 Jun 2011

 

On 31 May 2011 Yungjin Pharm.¡¯s asthma/COPD (Chronic obstructive pulmonary disease) medication development task was selected as ¡°Ministry of Knowledge Economy, futurity industry leading technology enterprise¡±

 

Existing asthma/COPD medication is used to relieve symptoms for management purpose. If this task is successfully implemented and products are successfully released for treatment of asthma and chronic obstructive pulmonary disease, then it will be a groundbreaking new drug product of natural substance with relatively few adverse events. 

 

Korean Market of asthma/COPD is about 219 billion KW and the world market is about 25trillion KW.  If Yungjin successfully develop the product it is expected to sale over 10billion KW in domestic market in 3 years of release and in the case of entering the overseas market it expects to reach 50 billion KW in 3 years of product release.
Press Room List page move

Quick menu